Form 4: Alignment Healthcare Executive Dawn Maroney Sells 30,000 Shares

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock on September 16, 2024, at a weighted-average price of $11.7009.

Summary

• Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock on September 16, 2024.
• The sale was executed at a weighted-average price of $11.7009 per share, with individual prices ranging from $11.44 to $12.07.
• Following the transaction, Maroney directly owns 1,756,097 shares of Alignment Healthcare.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, reporting an insider stock sale. The use of a 10b5-1 plan suggests the sale was pre-planned. The sentiment is neutral as it's a routine disclosure.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but pre-planned sales are generally viewed as less informative.

Stakeholder Impact

• The stock sale by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates